| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antigen-driven regulation of experimental autoimmune encephalomyelitis
|
Kuchroo, V.K.
|
|
1998
|
149 |
9 |
p. 771-781
11 p.
|
article
|
| 2 |
Antigen-driven regulation of experimental autoimmune encephalomyelitis
|
Kuchroo, V.K.
|
|
1998
|
149 |
9 |
p. 759-771
13 p.
|
article
|
| 3 |
Antigen receptors in lymphoid cell development and lymphocyte activation
|
Di Santo, J.P.
|
|
1998
|
149 |
9 |
p. 868-871
4 p.
|
article
|
| 4 |
Bystander suppression in experimental autoimmune encephalomyelitis: where and how does it occur?
|
Racke, M.K.
|
|
1998
|
149 |
9 |
p. 820-827
8 p.
|
article
|
| 5 |
Chemokine regulation of CNS T-cell infiltration in experimental autoimmune encephalomyelitis
|
Hoffman, L.M.
|
|
1998
|
149 |
9 |
p. 790-794
5 p.
|
article
|
| 6 |
Cytokines and antibodies in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis
|
Hjelmström, P.
|
|
1998
|
149 |
9 |
p. 794-804
11 p.
|
article
|
| 7 |
Immune cell entry to the CNS — a focus for immunoregulation of EAE
|
Owens, T.
|
|
1998
|
149 |
9 |
p. 781-789
9 p.
|
article
|
| 8 |
Immunoregulation of experimental autoimmune encephalomyelitis: editorial overview
|
Miller, S.D.
|
|
1998
|
149 |
9 |
p. 753-759
7 p.
|
article
|
| 9 |
Index of articles published
|
|
|
1998
|
149 |
9 |
p. 886-888
3 p.
|
article
|
| 10 |
Index of authors
|
|
|
1998
|
149 |
9 |
p. 881-885
5 p.
|
article
|
| 11 |
Index of key-words
|
|
|
1998
|
149 |
9 |
p. 885-886
2 p.
|
article
|
| 12 |
Pathogenic and protective responses in parasitic infections
|
Maizels, R.
|
|
1998
|
149 |
9 |
p. 875-877
3 p.
|
article
|
| 13 |
Pathogenic and protective T-cell responses in autoimmune diseases
|
Adorini, L.
|
|
1998
|
149 |
9 |
p. 873-875
3 p.
|
article
|
| 14 |
Peptide binding and editing: generation of TCR ligands
|
Hämmerling, G.J.
|
|
1998
|
149 |
9 |
p. 863-865
3 p.
|
article
|
| 15 |
Protective T-cell responses against tumours
|
Melief, C.
|
|
1998
|
149 |
9 |
p. 877-879
3 p.
|
article
|
| 16 |
Signalling through the TCR
|
Cantrell, D.
|
|
1998
|
149 |
9 |
p. 866-867
2 p.
|
article
|
| 17 |
T-cell design: optimizing the therapeutic potential of autoreactive T cells by genetic modification
|
Tuohy, V.K.
|
|
1998
|
149 |
9 |
p. 834-842
9 p.
|
article
|
| 18 |
TCR peptide-reactive T cells and peripheral tolerance to myelin basic protein
|
Kumar, V.
|
|
1998
|
149 |
9 |
p. 827-834
8 p.
|
article
|
| 19 |
Th1 and Th2 cells
|
Romagnani, S.
|
|
1998
|
149 |
9 |
p. 871-873
3 p.
|
article
|
| 20 |
The comeback of the elusive “suppressor” cell: an update on the regulatory network in EAE
|
Segal, B.M.
|
|
1998
|
149 |
9 |
p. 811-820
10 p.
|
article
|
| 21 |
Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease?
|
Willenborg, D.O.
|
|
1998
|
149 |
9 |
p. 804-810
7 p.
|
article
|
Journal description